NCT04880733

Brief Summary

Our goal is to use the R01 mechanism to conduct a two-arm multisite, feasibility RCT (Acupuncture vs Usual Care) to refine procedures for conducting a future fully powered multi-site RCT. The effort will be led by the BraveNet Coordinating Center at Einstein and include 3 BraveNet PBRN sites University Hospitals/ Case Western Reserve University (UH/Case), Vanderbilt University Medical Center (VUMC), and University of California-San Diego (UCSD). During Year 1 (Aim 1), we will develop the manualized acupuncture intervention with consensus from experts in the delivery of acupuncture for acute pain. At the end of Year 1 (prior to the start of the RCT), a study investigator meeting will be held to ensure consistent training of all study coordinators and acupuncturists to the study data collection, human subjects, intervention delivery, and reporting requirements. In Year 2-3 (Aim 2), we will enroll 165 participants (55 per site) into the randomized trial (1:1 assignment to Acupuncture or Usual Care) over a \~9-month enrollment period for each site. Sites will participate in the study sequentially, thus general findings from the implementation evaluation may be used to improve implementation at subsequent sites. Treatment outcomes include pain intensity, state anxiety and pain medication utilization within the ED (via EHR data extraction). In Aim 2a, 75 structured qualitative interviews of ED providers, staff, study acupuncturists (\~10 per site) and acupuncture patients (\~15 per site) and direct observation at each site will be used to identify barriers and facilitators of successful implementation. The Implementation Evaluation includes two broad categories of data: implementation outcomes (collected in Aim 2 as the feasibility study is conducted at each site) and explanatory factors (Aim 2a).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
290

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

May 3, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 11, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 24, 2022

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

February 20, 2024

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2025

Completed
Last Updated

January 5, 2026

Status Verified

December 1, 2025

Enrollment Period

1.4 years

First QC Date

April 30, 2021

Results QC Date

August 24, 2023

Last Update Submit

December 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Successful Recruitment of Participants Into the Study.

    The recruitment rate (# enrolled / # approached) were assessed for the overall study. Separate recruitment rates were calculated by site.

    At Enrollment

Secondary Outcomes (10)

  • Percentage of Participants Retained in the Study at Post Treatment

    At post treatment (45-60 minutes)

  • Percentage of Patients Retained at 1-week Follow up

    One-week after the participant was discharged from the ED

  • Patient Satisfaction Question 1 at Post-treatment

    At post-treatment (45-60 minutes after baseline)

  • Patient Satisfaction Question 2 at Post-treatment

    At post-treatment (45-60 minutes after baseline)

  • Patient Satisfaction Question 1 at 1-Week

    One week after participant was discharged from the ED

  • +5 more secondary outcomes

Study Arms (2)

Acupuncture

EXPERIMENTAL

This arm will receive acupuncture for pain management, and any pain medications will be delayed until after receipt of acupuncture.

Procedure: Acupuncture for pain managementOther: Usual care for pain management

Usual Care

ACTIVE COMPARATOR

This arm will receive usual care for pain management.

Other: Usual care for pain management

Interventions

A manualized acupuncture protocol will be performed by a licensed acupuncturist in the patient's emergency department room.

Acupuncture

Patient will receive usual care for pain management.

AcupunctureUsual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ≥18 years of age
  • Ability to communicate in English.
  • Level 3, 4, 5 on triage rate scale
  • Presentation with acute non-emergent (musculoskeletal, back, pelvic, non-cardiac chest, abdominal, flank or head) pain ≥4 on a 0-10-point NRS due to non-penetrating injury.

You may not qualify if:

  • Fever exceeding 100° F
  • Presenting with a chief complaint of a psychological / psychiatric concern
  • Presenting with chief complaint of Migraine
  • Patient arriving via ambulance or skipping triage
  • Current Pregnancy
  • Self-reported opioid medication taken orally within 4 hours
  • Presenting with chief complaint of Joint Dislocation
  • Presenting with chief complaint of Bone Fracture
  • Confirmed or suspected COVID-19

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

University of California San Diego

La Jolla, California, 92093, United States

Location

Einstein School of Medicine

The Bronx, New York, 10461, United States

Location

University Hospitals/Case Western Reserve University- Cleveland Medical Center

Cleveland, Ohio, 44106, United States

Location

Vandebilt University Medical Center

Nashville, Tennessee, 37232, United States

Location

Related Publications (5)

  • Dusek JA, Kallenberg GA, Storrow AB, Hughes RM, Coyne CJ, Vago DR, Nielsen A, Karasz A, Kim RS, Surdam J, Segall T, Faryar KA, Dyer NL, Barton BA, McKee MD. Acupuncture in the emergency department (ACUITY): Results from a BraveNet multi-center feasibility randomized controlled trial. Integr Med Res. 2024 Dec;13(4):101095. doi: 10.1016/j.imr.2024.101095. Epub 2024 Oct 21.

  • Nielsen A, Dyer NL, Lechuga C, McKee MD, Dusek JA. Fidelity to the acupuncture intervention protocol in the ACUpuncture In The EmergencY department for pain management (ACUITY) trial: Expanding the gold standard of STRICTA and CONSORT guidelines. Integr Med Res. 2024 Jun;13(2):101048. doi: 10.1016/j.imr.2024.101048. Epub 2024 May 10.

  • Dusek JA, Kallenberg GA, Hughes RM, Storrow AB, Coyne CJ, Vago DR, Nielsen A, Karasz A, Kim RS, Surdam J, Segall T, McKee MD. Acupuncture in the emergency department for pain management: A BraveNet multi-center feasibility study. Medicine (Baltimore). 2022 Mar 4;101(9):e28961. doi: 10.1097/MD.0000000000028961.

  • Nielsen A, Olson J, Quesada M, Zhu C, Raskin E, Vang B, Painovich J, Scott M, Xiong VJ, Dusek JA. Acupuncture intervention for acute pain in the Emergency Department trial: a consensus process. Acupunct Med. 2022 Aug;40(4):339-346. doi: 10.1177/09645284221076507. Epub 2022 Mar 1.

  • Dyer NL, Surdam J, Dusek JA. A Systematic Review of Practiced-Based Research of Complementary and Integrative Health Therapies as Provided for Pain Management in Clinical Settings: Recommendations for the Future and a Call to Action. Pain Med. 2022 Jan 3;23(1):189-210. doi: 10.1093/pm/pnab151.

MeSH Terms

Conditions

AgnosiaEmergenciesAcute Pain

Interventions

Acupuncture TherapyPain Management

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsDisease AttributesPathologic ProcessesPain

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsDisease ManagementPatient Care ManagementHealth Services Administration

Limitations and Caveats

It should be noted that recruitment was conducted during the COVID-19 pandemic.

Results Point of Contact

Title
Jeffery Dusek
Organization
University California-Irvine

Study Officials

  • Jeffery A Dusek, PhD

    University California-Irvine

    PRINCIPAL INVESTIGATOR
  • M. Diane McKee, MD

    University of Massachusetts, Worcester

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Data collector will be masked to study outcomes via electronic data collection
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 30, 2021

First Posted

May 11, 2021

Study Start

May 3, 2021

Primary Completion

September 24, 2022

Study Completion

August 31, 2025

Last Updated

January 5, 2026

Results First Posted

February 20, 2024

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations